Granotapide

Star0

DB12934InvestigationalSmall molecule

Granotapide has been used in trials studying the treatment of Type II Diabetes Mellitus.

Formula / weight: C₃₉H₃₇F₃N₂O₈ · 718.726 g/mol (avg)
Code names: JTT-130

Resolves to

Compound

UNIIPSZ2YGB0DKCAS594842-13-4PubChem11607299

Structure

InChIKeyFPUQGCOBYOXAED-UHFFFAOYSA-NSMILESCCOC(=O)C(COC(=O)CC1=CC=C(NC(=O)C2=CC=CC=C2C2=CC=C(C=C2)C(F)(F)F)C(=C1)C(=O)N(C)C)(C(=O)OCC)C1=CC=CC=C1

Targets

P55157MTTP

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Granotapide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account